Jim Simons Entera Bio Ltd. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Entera Bio Ltd. stock. As of the latest transaction made, Renaissance Technologies LLC holds 57,600 shares of ENTX stock, worth $115,775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,600
Previous 74,900
23.1%
Holding current value
$115,775
Previous $125,000
16.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ENTX
# of Institutions
17Shares Held
5.31MCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL3.88MShares$7.8 Million4.83% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY672KShares$1.35 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT402KShares$807,0510.11% of portfolio
-
Ubs Group Ag168KShares$336,9220.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA28.9KShares$58,0000.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $57.9M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...